Return
Clinically Applicable Deep Learning Algorithm Using Quantitative Proteomic Data
DOI:10.1021/acs.jproteome.9b00268.png)
Abstract
En 中文
Deep learning (DL), a type of machine learning approach, is a powerful tool for analyzing large sets of data that are derived from biomedical sciences. However, it remains unknown whether DL is suitable for identifying contributing factors, such as biomarkers, in quantitative proteomics data. In this study, we describe an optimized DL-based analytical approach using a data set that was generated by selected reaction monitoring-mass spectrometry (SRM-MS), comprising SRM-MS data from 1008 samples for the diagnosis of pancreatic cancer, to test its classification power. Its performance was compared with that of 5 conventional multivariate and machine learning methods: random forest (RF), support vector machine (SVM), logistic regression (LR), k-nearest neighbors (k-NN), and naive Bayes (NB). The DL method yielded the best classification (AUC 0.9472 for the test data set) of all approaches. We also optimized the parameters of DL individually to determine which factors were the most significant. In summary, the DL method has advantages in classifying the quantitative proteomics data of pancreatic cancer patients, and our results suggest that its implementation can improve the performance of diagnostic assays in clinical settings.
Keywords:
deep learning
machine learning
SRM-MS
targeted proteomics
mass spectrometry
Journal
IF:
3.6
Papers:
9.4K
Citations:
2.9W
Organization
Cited Papers
The MicroArray Quality Control (MAQC)-IIII study of common practices for the development and validation of microarray-based predictive models
NATURE BIOTECHNOLOGY
IF41.7
Clinical Assay for AFP-L3 by Using Multiple Reaction Monitoring-Mass Spectrometry for Diagnosing Hepatocellular Carcinoma
CLINICAL CHEMISTRY
IF6.3

